Study of PYX-201 in Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

May 31, 2027

Conditions
Solid TumorAdvanced Solid Tumor
Interventions
DRUG

PYX-201

IV infusion

Trial Locations (20)

1070

RECRUITING

Institut Jules Bordet, Brussels

1200

RECRUITING

Cliniques Universitaires Saint-Luc, Brussels

2650

RECRUITING

Universitair Ziekenhuis Antwerpen, Edegem

9000

RECRUITING

Universitair Ziekenhuis Gent, Ghent

22031

RECRUITING

NEXT Virginia, Fairfax

28040

RECRUITING

START Madrid - Hospital Universitario Fundación Jiménez Díaz, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28050

RECRUITING

Hospital Universitario HM Sanchinarro, Madrid

34232

RECRUITING

SCRI - Florida Cancer Specialists, Sarasota

46010

RECRUITING

Hospital Clínico Universitario de Valencia, Valencia

60637

RECRUITING

University of Chicago Medicine, Chicago

75231

RECRUITING

NEXT Dallas, Dallas

78229

RECRUITING

NEXT San Antonio, San Antonio

80218

RECRUITING

SCRI - HealthOne Denver, Denver

85258

RECRUITING

HonorHealth Research Institute, Scottsdale

02114

RECRUITING

Massachusetts General Hospital, Boston

63110-1010

RECRUITING

Washington University School of Medicine, St Louis

02903

RECRUITING

Rhode Island Hospital, Providence

08035

RECRUITING

Hospital Universitari Vall d'Hebrón, Barcelona

W1G 6AD

RECRUITING

Sarah Cannon Research Institute London, London

All Listed Sponsors
lead

Pyxis Oncology, Inc

INDUSTRY